MI-503
Product Specifications
UNSPSC Description
MI-503 is a highly potent and orally bioavailable small molecule inhibitor of the menin-mLL interaction.
Target Antigen
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/MI-503.html
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
FC(F)(F)CC(S1)=CC2=C1N=CN=C2NC3CCN(CC4=CC=C(N(CC5=CNN=C5)C(C#N)=C6)C6=C4C)CC3
Molecular Weight
564.63
References & Citations
[1]Borkin D, et al. Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo. Cancer Cell. 2015 Apr 13;27(4):589-602.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-16925/MI-503-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-16925/MI-503-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1857417-13-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Ethyl 4- (1,3-dioxo-1H-benzo[de]isoquinolin-2 (3H) -yl) butanoate](https://cdn.genprice.uk/genprice/genprice2.png)
OR303932-01 500 mg
Ethyl 4- (1,3-dioxo-1H-benzo[de]isoquinolin-2 (3H) -yl) butanoate
Ask
View Details 
MBS6360642-01 0.2 mL
UBE2D3, CT (UBE2D3, UBC5C, UBCH5C, Ubiquitin-conjugating enzyme E2 D3, Ubiquitin carrier protein D3, Ubiquitin-conjugating enzyme E2(17)KB 3, Ubiquitin-conjugating enzyme E2-17kD 3, Ubiquitin-protein ligase D3) (Biotin)
Ask
View Details 
MBS6360642-02 5x 0.2 mL
UBE2D3, CT (UBE2D3, UBC5C, UBCH5C, Ubiquitin-conjugating enzyme E2 D3, Ubiquitin carrier protein D3, Ubiquitin-conjugating enzyme E2(17)KB 3, Ubiquitin-conjugating enzyme E2-17kD 3, Ubiquitin-protein ligase D3) (Biotin)
Ask
View Details